Search research articles
Contact Us
Filters
Showing results (41-50 of 161) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
October 30, 2025
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models
Arjanneke F van de Merbel, Maaike H van der Mark, Tilly Aalders, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 24, 2007
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations
Judith Y M N Engwegen, Niven Mehra, John B A G Haanen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 3, 2023
<sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer
Anouk C de Jong, Marcel Segbers, Sui Wai Ling, et al.
JCO Precision Oncology
|
July 8, 2026
Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer
Peter H J Slootbeek, Yarah M Quint, Julian J R Kokke, et al.
JCO Precision Oncology
|
January 20, 2022
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate Cancer
Sofie H Tolmeijer, Emmy Boerrigter, Jack A Schalken, et al.
Clinical Pharmacokinetics
|
May 4, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer
Catharina J P Op 't Hoog, Niven Mehra, Benthe van der Weij, et al.
European Urology Focus
|
September 18, 2021
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study
Anke Richters, Joost L Boormans, Michiel S van der Heijden, et al.
Cancer Treatment and Research Communications
|
December 14, 2020
Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study
Anke Richters, Niven Mehra, Richard P Meijer, et al.
BJU International
|
December 4, 2024
The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study
Jikke Bosveld, Tri Q Nguyen, Joost L Boormans, et al.
Genome Medicine
|
March 21, 2025
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
Daniel J Vis, Sander A L Palit, Marie Corradi, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 161) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
October 30, 2025
Anti-neoplastic effects of the antipsychotic drug penfluridol in preclinical prostate cancer models
Arjanneke F van de Merbel, Maaike H van der Mark, Tilly Aalders, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 24, 2007
Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations
Judith Y M N Engwegen, Niven Mehra, John B A G Haanen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 3, 2023
<sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer
Anouk C de Jong, Marcel Segbers, Sui Wai Ling, et al.
JCO Precision Oncology
|
July 8, 2026
Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer
Peter H J Slootbeek, Yarah M Quint, Julian J R Kokke, et al.
JCO Precision Oncology
|
January 20, 2022
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate Cancer
Sofie H Tolmeijer, Emmy Boerrigter, Jack A Schalken, et al.
Clinical Pharmacokinetics
|
May 4, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer
Catharina J P Op 't Hoog, Niven Mehra, Benthe van der Weij, et al.
European Urology Focus
|
September 18, 2021
Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study
Anke Richters, Joost L Boormans, Michiel S van der Heijden, et al.
Cancer Treatment and Research Communications
|
December 14, 2020
Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study
Anke Richters, Niven Mehra, Richard P Meijer, et al.
BJU International
|
December 4, 2024
The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study
Jikke Bosveld, Tri Q Nguyen, Joost L Boormans, et al.
Genome Medicine
|
March 21, 2025
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
Daniel J Vis, Sander A L Palit, Marie Corradi, et al.
Page
of 17